186 related articles for article (PubMed ID: 22200387)
1. Pilot study assessing the impact of intrathecal baclofen administration mode on sleep-related respiratory parameters.
Bensmail D; Marquer A; Roche N; Godard AL; Lofaso F; Quera-Salva MA
Arch Phys Med Rehabil; 2012 Jan; 93(1):96-9. PubMed ID: 22200387
[TBL] [Abstract][Full Text] [Related]
2. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
Stokic DS; Yablon SA; Hayes A
Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
[TBL] [Abstract][Full Text] [Related]
5. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
[TBL] [Abstract][Full Text] [Related]
6. [Results of intrathecal baclofen therapy on spasticity in patients with brain injury].
Dénes Z; Klauber A; Both B; Lóránd E
Ideggyogy Sz; 2012 Jul; 65(7-8):243-8; discussion 248. PubMed ID: 23074844
[TBL] [Abstract][Full Text] [Related]
7. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; Pittalà G; Castiglione A; Patti F; Mangiameli S
Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
[TBL] [Abstract][Full Text] [Related]
8. Functional outcome of intrathecal baclofen administration for severe spasticity.
Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief.
McClelland S; Bethoux FA; Boulis NM; Sutliff MH; Stough DK; Schwetz KM; Gogol DM; Harrison M; Pioro EP
Muscle Nerve; 2008 Mar; 37(3):396-8. PubMed ID: 17894358
[TBL] [Abstract][Full Text] [Related]
10. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
[TBL] [Abstract][Full Text] [Related]
11. [The parents expectations after baclofen pump implantation in child with severe spasticity in physical rehabilitation and psychological aspects].
Fafara A; Kwiatkowski S; Kawecka J; Grzegorzewski P; Kawecki Z
Przegl Lek; 2007; 64 Suppl 2():18-21. PubMed ID: 17953274
[TBL] [Abstract][Full Text] [Related]
12. Effect of concentration and mode of intrathecal baclofen administration on soleus H-reflex in patients with muscle hypertonia.
Stokic DS; Yablon SA
Clin Neurophysiol; 2012 Nov; 123(11):2200-4. PubMed ID: 22595326
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore.
Wang ZM; Law JH; King NK; Rajeswaran DK; Soh S; Rao JP; Ng WH; Chua KS
Singapore Med J; 2016 Jan; 57(1):8-12. PubMed ID: 26831310
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.
Bensmail D; Ward AB; Wissel J; Motta F; Saltuari L; Lissens J; Cros S; Beresniak A
Neurorehabil Neural Repair; 2009; 23(6):546-52. PubMed ID: 19228818
[TBL] [Abstract][Full Text] [Related]
15. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
[TBL] [Abstract][Full Text] [Related]
16. Goals and outcomes for non ambulant children receiving continuous infusion of intrathecal baclofen.
Gray N; Morton RE; Brimlow K; Keetley R; Vloeberghs M
Eur J Paediatr Neurol; 2012 Sep; 16(5):443-8. PubMed ID: 22277771
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.
Stetkarova I; Brabec K; Vasko P; Mencl L
Pain Physician; 2015; 18(4):E633-41. PubMed ID: 26218954
[TBL] [Abstract][Full Text] [Related]
18. Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients.
Plassat R; Perrouin Verbe B; Menei P; Menegalli D; Mathé JF; Richard I
Spinal Cord; 2004 Dec; 42(12):686-93. PubMed ID: 15303111
[TBL] [Abstract][Full Text] [Related]
19. [Intrathecal baclofen for severe spasticity].
Ueta T
Brain Nerve; 2008 Dec; 60(12):1415-20. PubMed ID: 19110752
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Dosing of Intrathecal Baclofen in the Treatment of Spasticity After Acquired Brain Injury.
Maneyapanda MB; McCormick ZL; Marciniak C; Reger C
PM R; 2017 Jun; 9(6):556-562. PubMed ID: 28082177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
